Redemann; Norbert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Redemann; Norbert.The latest application filed is for "halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions".

Company Profile

0.16.12

Redemann; Norbert - Biberach DE
Redemann; Norbert - Biberach an der Riss DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions Grant 8,853,193 - Heckel , et al. October 7, 2	2014-10-07
Cycloalkyl containing thienopyrimidines for pharmaceutical compositions Grant 8,754,079 - Lehmann-Lintz , et al. June 17, 2	2014-06-17
Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions Grant 8,648,068 - Lehmann-Lintz , et al. February 11, 2	2014-02-11
Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use Grant 8,614,238 - Kley , et al. December 24, 2	2013-12-24
Halogen Or Cyano Substituted Thieno [2,3-d]pyrimidines Having Mnk1/mnk2 Inhibiting Activity For Pharmaceutical Compositions App 20130065914 - Heckel; Armin ; et al.	2013-03-14
Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use App 20130053412 - Kley; Joerg ; et al.	2013-02-28
Heterocycloalkyl-containing Thienopyrimidines For Pharmaceutical Compositions App 20110212102 - LEHMANN-LINTZ; Thorsten ; et al.	2011-09-01
Thienopyrimidines Containing A Substituted Alkyl Group For Pharmaceutical Compositions App 20110212103 - HECKEL; Armin ; et al.	2011-09-01
2-benzylaminodihydropteridinones, process for their manufacture and use thereof as medicaments Grant 7,759,347 - Hoffmann , et al. July 20, 2	2010-07-20
2-benzylaminodihydropteridinones, process for their manufacture and use thereof as medicaments App 20090124628 - HOFFMANN; Matthias ; et al.	2009-05-14
Dihydropteridione derivatives, process for their manufacture and their use as medicament Grant 7,332,491 - Grauert , et al. February 19, 2	2008-02-19
New dihydropteridione derivatives, process for their manufacture and their use as medicament App 20060052383 - Grauert; Matthias ; et al.	2006-03-09
2-Benzylaminodihydropteridinones, process for their manufacture and use thereof as medicaments App 20060004014 - Hoffmann; Matthias ; et al.	2006-01-05
Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs Grant 6,855,710 - Walter , et al. February 15, 2	2005-02-15
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions Grant 6,806,272 - Bauer , et al. October 19, 2	2004-10-19
Methods of using dihydropteridinones App 20040147524 - Bauer, Eckhart ; et al.	2004-07-29
Substituted indolines which inhibit receptor tyrosine kinases Grant 6,762,180 - Roth , et al. July 13, 2	2004-07-13
Novel substituted indolines with an inhibitory effect on various kinases and complexes of CDKs App 20040058978 - Walter, Rainer ; et al.	2004-03-25
New dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions App 20040029885 - Bauer, Eckhart ; et al.	2004-02-12
Substituted indolinones with kinase inhibitory activity Grant 6,319,918 - Heckel , et al. November 20, 2	2001-11-20
Indolinones having kinase inhibitory activity Grant 6,169,106 - Heckel , et al. January 2, 2	2001-01-02
Indolinones having kinase-inhibiting activity Grant 6,043,254 - Grell , et al. March 28, 2	2000-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.